ARTICLE | Company News
Geron other research news
September 18, 1995 7:00 AM UTC
Geron received a six month, $96,000 Phase I SBIR from the National Institutes of Health to develop telomerase assays as cancer diagnostic and prognostic products. The company will use the assays to de...